Comparative evaluation between chitosan and atorvastatin on serum lipid profile changes in hyperlipidemic cats

The purpose of the present survey was to determine the effects of the chitosan and atorvastatin on serum lipid profile changes and the influence of time on treatment process in cats. For the management of cholesterol induced hyperlipidemia, twenty-one healthy cats were randomly divided into three equal groups. Group A (control) included seven cats that were fed with cholesterol powder (4 g/kg for 10 days). Group B was similar to group A, but in addition, atorvastatin (5 mg/kg) was administered for 45 days after induced hyperlipidemia. Group C was similar to group B, but chitosan (3 g/cat) was administered instead of atorvastatin. Blood samples were collected four times on days 0, 10, 40 and 55 after challenge. Serum total cholesterol, triglycerides, HDL-C and LDL-C levels were measured using standard commercial kits. Atorvastatin (P